ISTH 2021 Congress
Arterial Thromboembolism » Atherosclerosis
Theme Navigation
- ISTH 2021 Congress
- Arterial Thromboembolism
- Atherosclerosis
- Arterial Thromboembolism
-
Abstract Number: LPB0048
Association between Plaque Vulnerability and Neutrophil Extracellular Traps (NETs) Levels: The Plaque at RISK Study
-
Abstract Number: PB0009
Combined Focused Ultrasound and Electrohydraulic Shock Wave Thrombolytic Therapy Accompanied by Tissue Plasminogen Activator Administration Reduce Thrombus Content in the Arterial Atherothrombotic Stenosis
-
Abstract Number: LPB0096
Development of a 3D Tissue-engineered Neointimal Model as an Alternative to Animal Models of Human Atherosclerosis
-
Abstract Number: OC 36.3
Immature Platelet Count is Associated with Platelet Functional Responses in Patients Receiving Aspirin
-
Abstract Number: OC 17.2
Increased Levels of Coagulation Factor V in Atherosclerotic Plaques – An Immune Regulated Response?
-
Abstract Number: PO111
Intermediate Stage Atherosclerosis Regression Using Lipid-based Encapsulated Methotrexate Nanoparticles-mediated B-mode Ultrasound-guided Pulsed Low Level Focused Ultrasound Sonoporation Therapy
-
Abstract Number: PB0010
Investigation of Red Blood Cells Influence on Atherosclerotic Plaque by Scanning Flow Cytometry
-
Abstract Number: LPB0097
Role of Low-dose Aspirin on the Release of Circulating Microvesicles in Patients at Cardiovascular Risk with and without Type 2 Diabetes
-
Abstract Number: PO106
Stable Fibroatheromatic Plaque Regression Using High-dose Atorvastatin-loaded PESDA Microbubbles-mediated Extracorporeal Shock Wave Sonoporation Therapy
-
Abstract Number: PB0007
The Role of TEC Family Kinases in oxLDL-mediated Platelet Activity in vitro and Platelet and Endothelial Dysfunction in vivo
-
Abstract Number: PB0008
Tissue Inhibitor of Metalloproteinases-1 (TIMP1) is Related to Residual Thromboxane Dependent Platelet Activation in Patients with Type 2 Diabetes Mellitus Receiving Low Dose Aspirin